Applied Microbiology and Biotechnology

, Volume 23, Issue 1, pp 5–9 | Cite as

Continuous production of human leukocyte interferon withEscherichia coli and continuous cell lysis in a two stage chemostat

  • Stephen W. Brown
  • Hans-Peter Meyer
  • Armin Fiechter
Article

Summary

The continuous production and extrac-tion of human leukocyte interferon (type α2) in a two stage chemostat is described. Interferon con-tainingEscherichia coli cells were produced in the first stage and transferred to the second stage, where the cells were lysed continuously by the ad-dition of ampicillin. The medium used was based on corn steep liquor. Highest interferon titres and the best extraction efficiencies were achieved when running the first and second stages at dilution rates of 0.3 h−1 and 0.1 h−1, and at temperatures of 30° C and 25 °C, respectively. In order to prevent loss of interferon in the second stage, oxygen limitation had to be avoided. For optimal cell lysis there should be excess glucose in the second stage and the ampicillin concentration should be maintained above 100 mg 1−1.

Keywords

Interferon Dilution Rate Corn Steep Liquor Interferon Production Ampicillin Concentration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Emerick AE, Bertolani BL, Ben-Basset A, White TJ, Konrad MW (1984) Expression of a β-lactamase preproinsulin fusion protein inEscherichia coli. Biotechnology 2:165–173CrossRefGoogle Scholar
  2. Finter NB (1969) Dye uptake methods of assessing viral cytopathogenicity and their application of interferon assays. J Gen Virol 5:419–425CrossRefGoogle Scholar
  3. Guerra-Santos L, Käppeli O, Fiechter A (1984)Pseudomonas aeruginosa biosurfactant production in continuous culture with glucose as carbon source. Appl Environ Microbiol 48:301–305Google Scholar
  4. Kuhn H, Friederich U, Fiechter A (1979) Defined minimal medium for a thermophilicBacillus sp. developed by a chemostat pulse and shift technique. Eur J Appl Microbiol Biotechnol 6:341–349CrossRefGoogle Scholar
  5. Meyer H-P, Kuhn H-J, Brown SW, Fiechter A (1984) Production of human leukocyte interferon byEscherichia coli. Proceedings of the 3rd European Congress on Biotechnology: Vol 1, 499–505Google Scholar
  6. Nagata S, Taira H, Hall A, Johnsrud L, Streuli M, Ecsoedi J, Ball W, Cantell K, Weissmann C (1980) Synthesis inE. coli of a polypeptide with human leukocyte interferon activity. Nature 284:316–320CrossRefGoogle Scholar
  7. Reiling H, Laurila H, Fiechter A (1985) Medium development for low and high density cultivation ofEscherichia coli B/R in minimal and complex media. J Biotechnol 2:191–206CrossRefGoogle Scholar
  8. Toda K, Takeuchi T, Sano H (1983) Growth rate dependence of enzyme synthesis in chemostat cultures: α-amylase, β-galactosidase and β-fructosidase. J Chem Tech Biotechnol 29:747–755Google Scholar
  9. Zabriskie DW, Arminger WB, Phillips DH, Albano PA (1980) Traders guide to fermentation media. Traders Oil Mill Co., Fort Worth, Texas 76101, USAGoogle Scholar

Copyright information

© Springer-Verlag 1985

Authors and Affiliations

  • Stephen W. Brown
    • 1
    • 2
  • Hans-Peter Meyer
    • 1
  • Armin Fiechter
    • 1
  1. 1.Swiss Federal Institute of Technology, Department of BiotechnologyETH HönggerbergZürichSwitzerland
  2. 2.Fermentation DepartmentTRANSGENE SAStrasbourgFrance

Personalised recommendations